Supplies for intraluminal procedures of the heart and blood vessels

This tender for cardiovascular intraluminal procedure supplies is generally well-structured with clear requirements and comprehensive documentation, promoting fair competition and transparency. However, minor data inconsistencies and a lack of sustainability focus are noted.

The tender demonstrates good legal compliance with reasonable submission deadlines (30 days), a specific CPV code, and no reported disputes. The inclusion of mandatory exclusion grounds related to the Russian Federation reflects adherence to current regulations. Minor details like N/A codes for procedure type and missing NUTS code are slight detractions.

Clarity is a strong point, with a clear description, well-documented and understandable requirements across all categories (eligibility, technical, financial, submission), and explicitly defined evaluation criteria with weightings. The AI-extracted requirements are comprehensive and precise.

The tender is largely complete, providing all basic information, estimated value, and a clear 3-year duration. A comprehensive set of 14 documents, including multiple draft framework agreements and detailed technical specifications, is provided. The primary gap is the missing NUTS code for location information.

Fairness is well-addressed through full document access, a disclosed estimated value, reasonable deadlines, and objective, transparent evaluation criteria. Electronic submission and e-procurement promote equal access. While technical requirements are highly specific for medical devices, this is often necessary for quality and patient safety, and the 'Divided into Parts' characteristic helps mitigate potential competition limitations.

The tender supports electronic submission and e-procurement, enhancing practicality. The contract start date is clearly linked to signing, which is pragmatic. However, a direct document URL is not explicitly provided (though implied by the e-procurement platform), and specific financing sources are not detailed beyond the estimated value.

While dates are logical and no disputes are reported, a significant inconsistency exists with 'Estimated Value: 8,500,000.00 EUR' being explicitly stated alongside 'Value Classified: Yes'. This contradiction creates ambiguity.

The tender lacks explicit criteria for green procurement, social aspects, or innovation. It is also not EU-funded, which often correlates with higher sustainability standards. This represents a missed opportunity to integrate broader public value considerations.